Weightcare ~
Medi-Cal to End GLP-1 Weight-Loss Coverage in 2026: What California Patients Need to Know.
** The Researching Beauty Blog may earn a small commission from any sales generated through our affiliate links and codes. We appreciate all of your love and support. **
Introduction.
I’ve been on a GLP-1 medication for about a year now. I’m 38 years old, and I’ve been overweight for roughly eight years — the kind of weight that felt like it would stick around forever. Finally, I got myself started on a GLP-1 shot (the weekly kind). Over the past 12 months I’ve steadily lost weight — about 40 lbs so far — and I genuinely felt like I was finally making headway, even though I had plenty of room to go. But now I’m faced with the risk of losing it.
Starting January 1, 2026, in California my coverage through Medi‑Cal will no longer cover GLP-1 drugs when they’re prescribed solely for weight loss. I’ll have to start paying monthly for my medication myself — and one source of quotes I found says I might be looking at $500–$1,200 per month, just to maintain this shot. That’s crazy. This article is about what this change means for me — and for all Californians on Medi-Cal who are using or hoping to use GLP-1 drugs for weight-loss purposes.
What’s changing: Coverage under Medi-Cal and when GLP-1s won’t be covered.
Beginning January 1, 2026, California’s Medi-Cal program is set to eliminate coverage for GLP-1 receptor agonist medications when they are used for weight loss or weight-related indications. Coverage will continue under Medi-Cal for GLP-1 drugs when they are used for FDA-approved non-weight-loss indications (such as treating type 2 diabetes) and when an appropriate diagnosis code (ICD-10) supports that indication.
Here are further details:
• The change is part of the state budget and pharmacy benefit adjustments by the California Department of Health Care Services, aiming to reduce pharmacy spending and improve program integrity.
• The budget documents show this under “Specialty Drug Coverage for Weight Loss — Elimination of coverage for Glucagon-Like Peptide-1 (GLP-1) drugs for weight loss, effective January 1, 2026.”
• An estimate from the governor’s office shows savings of about $85 million in 2025-26 from cutting these drugs, growing to up to $680 million by 2028-29.
• It’s important to stress: This does not fully stop all GLP-1 coverage under Medi-Cal — only when the indication is weight-loss. If your doctor prescribes the same drug for type 2 diabetes or other approved conditions, coverage remains.
Who will this affect?
• Low-income Californians enrolled in Medi-Cal who are currently using GLP-1 medications for weight loss (or weight-related conditions) will have to switch to paying out of pocket (or find another insurance) after January 1, 2026.
• People who are hoping to start a GLP-1 for weight loss and rely on Medi-Cal will find that after that date, the drug is not covered for that purpose — so the financial barrier becomes extreme (many of these drugs cost over $1,000/month).
• Those who use GLP-1s for diabetes or other approved uses will be less directly impacted (though there may be indirect effects such as increased scrutiny).
• The policy has stirred concern among health-care experts because they fear many people may regain weight or lose the health benefits they've gained (lower blood pressure, cholesterol, etc.) since losing access to a tool they were using.
For me personally, this means that I’m facing the possibility of losing coverage for something that finally started working for me — which is scary and frustrating.
What are GLP-1 medications and how do they work for weight loss?
GLP-1 stands for glucagon-like peptide-1. These are receptor agonist medications that mimic the natural GLP-1 hormone in the gut/brain axis to regulate appetite, insulin secretion, and many other metabolic processes.
Here’s a breakdown of how they work and their history:
• Originally, GLP-1 receptor agonists were developed and approved to treat type 2 diabetes — they help by enhancing insulin secretion (when glucose is high), inhibiting glucagon (which raises glucose), and slowing gastric emptying. For example, the drug Semaglutide (brand names Ozempic, Rybelsus) was first for diabetes.
• Doctors began noticing that people on these medications lost weight significantly. That led to approvals for weight management in certain drugs (for example, semaglutide under the brand name Wegovy).
Mechanisms for weight-loss:
• Appetite suppression: GLP-1 drugs activate receptors in the brain (especially hypothalamus) to reduce hunger signals and increase satiety.
• Slowed gastric emptying: Food stays in the stomach longer, so you feel fuller longer and eat less.
• Reduced cravings: Some studies show that GLP-1s change food preferences, reducing drive for high-fat or high-energy foods.
• Metabolic improvements: Better insulin sensitivity, less fat storage, more fat breakdown. Over time these contribute to sustained weight loss when combined with diet/exercise.
• Clinical trial results: For instance, in trials of semaglutide for weight management, when combined with diet and exercise interventions, participants lost on average around 10-15% of their initial body weight over 68 weeks. (Of course individual results vary.)
In summary, GLP-1 drugs help create a calorie deficit not just by telling you to eat fewer calories, but by changing the physiology of hunger, fullness, and metabolism — making diet and exercise more effective and sustainable.
So when I say I’ve been on a GLP-1 shot and seen real progress, that’s the mechanism working in my body, alongside the diet changes I’ve made.
My experience with GLP-1 medications.
I’m on the weekly shot of Wegovy (semaglutide). I worked really hard to get my doctor on board and to get the dose right. The beginning wasn’t easy. Side-by-side with the good results, I had to push through some unpleasant effects:
• When I was ramping up the dose: stomach pain, nausea, constipation, mild headaches. I had zero appetite. Some days I intuitively felt full after almost nothing.
• Over time I got used to it. Now I’ve been at the highest/maintenance dose for a bit, and the side-effects have eased.
• Results: I’ve lost about 40 lbs so far. That feels huge to me — especially because I hadn’t taken the journey super seriously before. I’m eating much less than I did, and better quality food, but exercise is where I lag behind.
• My particular situation: I work from home, so I'm sitting most of the day unless I'm cleaning or taking care of my son. I don’t go out much — I don’t even like leaving my house. My husband has to drive everywhere because I’m legally blind in my left eye and half‐blind in my right. So driving is off the table for me.
• Because exercise has been minimal, I know I haven’t lost as much weight as I could have. The medication is doing a heavy lift, but I still have a lot of work to do.
• Now, with the risk of losing access to the medication (or having to pay out of pocket hundreds or thousands per month), I’m filled with regret that I might lose momentum. It’s not just my health; it’s my emotional investment, my effort, and my hope.
It feels like we’re all in this together — every person in California on Medi-Cal using GLP-1s for weight loss is facing the same cliff. If the coverage goes away January 1st, the interruption could erode the progress we’ve made.
How you (my audience) can get your GLP-1 medications prescribed online.
Since coverage through Medi-Cal is going away for weight-loss indication, many people are already looking at alternative routes. One good option I found and personally support is the online service called Weightcare. Here’s how that works:
• You go to Weightcare’s website and schedule a virtual appointment with one of their licensed doctors.
• During the appointment, the doctor evaluates your health-history, checks if you’re a good fit for GLP-1 medications (for weight-loss), and determines which type (if any) is appropriate for you.
• No traditional insurance is required (Weightcare generally doesn’t bill insurance for this service). You pay for the prescription (and in many cases the consultation cost is wrapped into it).
• The program also includes support: a licensed dietician, a nutritionist, helping you through your journey (meal guidance, support, supplements, etc.).
• You’ll also find options for protein powders and other vitamins/supplements to assist your weight loss journey.
• It’s more affordable compared to traditional pharmacy pricing when insurance drops out.
Bonus: I happen to have a special discount code for my audience to use with Weightcare. If you’re ready to get started, you can use the code to save some extra money at checkout.
If you’re worried about what happens after January 2026 with Medi-Cal, it might be smart to check out this option now. That way you’re not caught scrambling after the cutoff date.
Which GLP-1 drugs are available through Weightcare?
Semaglutide & Tirzepatide
Weightcare currently offers two major options: semaglutide and tirzepatide. Both are excellent, but there are differences. Here is a detailed breakdown:
• Prescription medication in the GLP-1 receptor agonist class.
• Initially approved for type 2 diabetes (brands Ozempic, Rybelsus), later approved for weight management under brand name Wegovy.
Why it’s good for weight loss:
• Suppresses appetite and increases fullness via brain hunger centres.
• Slows gastric emptying (so you feel full longer).
• Reduces cravings, especially for high-fat or high-energy foods.
• Improves metabolic function (better insulin sensitivity, more fat breakdown).
• Clinical trials: when combined with diet/exercise, average weight loss 10-15% of starting body weight over 68 weeks.
• In essence: semaglutide helps you eat less, feel less hungry, and maintain weight loss more easily through its physiologic effects.
• Prescription medication approved for chronic weight management (brand name Zepbound) and for type 2 diabetes (brand name Mounjaro). It’s a “dual” agent: activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors.
Why it’s good for weight loss:
• Dual action: targets both GIP and GLP-1, giving a stronger effect on appetite, metabolism, and fat loss.
• Appetite suppression + delayed gastric emptying + improved metabolic health (even more so than GLP-1 alone).
• Clinical trials show weight-loss of 15-21% of starting body weight over 72 weeks (depending on dose) — results comparable to some bariatric surgery.
• It’s a next-level option for people who want or need stronger results and are medically appropriate.
Comparing Semaglutide & Tirzepatide.
Here’s how they stack up — similarities and key differences:
Similarities:
• Both are injectable (in their current approved forms) and are taken (in many cases) weekly.
• Both act to reduce appetite, increase fullness, slow gastric emptying, and improve metabolic health.
• Both are meant to be used in conjunction with reduced-calorie diet + increased physical activity (they’re not “magic bullets” alone).
• Both are prescription-only and require medical oversight.
Differences:
• Mechanism: Semaglutide works purely via GLP-1 receptor agonism. Tirzepatide works via dual GIP + GLP-1 receptor agonism, which means a broader mechanism and generally more potent effect.
• Weight-loss magnitude: While results vary individually, tirzepatide has shown somewhat greater average weight loss in trials compared to semaglutide (15-21% vs 10-15%, under ideal conditions).
• Side-effect profile and tolerability may differ slightly; with stronger action comes potential for stronger side effects (though individual experiences vary).
• Cost and insurance coverage: In many cases tirzepatide may cost more (depending on dose/brand) and may have stricter criteria for coverage.
• Medical suitability: Some patients may be better suited for one vs the other based on comorbidities (diabetes, cardiovascular disease), medical history, side-effect tolerance, etc.
So when choosing between semaglutide vs tirzepatide, it’s a decision made with your doctor (or Weightcare’s doctor) based on your weight-loss goals, health history, budget, and willingness / capacity for lifestyle changes.
How my audience can get set up through Weightcare.
Here’s a step-by-step guide for you (my reader) to get started:
• Visit Weightcare’s website (type in Weightcare, find their virtual weight-loss/GLP-1 program).
• Schedule a free virtual consultation with one of their licensed doctors. During that visit you’ll discuss your health history, weight-loss goals, possible contraindications, etc.
• The doctor determines if you’re a good candidate for a GLP-1 medication (for weight-loss), and if yes, picks the appropriate drug (semaglutide or tirzepatide).
• Prescription is written and shipped (or arranged) to you. You’re enrolled in the program that includes support: dietician, nutritionist, supplements, protein powders, etc.
• During checkout / enrollment, make sure to use my special discount code (which I’ll share) to save you extra money.
• Begin your regimen and follow the supporting lifestyle program (even if you’re working from home, minimal exercise; plan to gradually improve that).
• Ideally, you want to set this up before January 1, 2026 (if you are currently covered by Medi-Cal for weight-loss GLP-1s) so you don’t face a gap in treatment or risk losing your momentum.
If you’re reading this and thinking: “I need a backup plan because Medi-Cal coverage might vanish,” this is that backup plan. You don’t have to wait until the last minute, but the earlier you start the process the smoother it will go.
Summary of everything we’ve talked about.
Let’s recap:
• I’m 38, overweight for 8 years, on a weekly GLP-1 shot (Wegovy/semaglutide) for about a year, lost 40 lbs, dealing with side-effects early, minimal exercise due to working from home and vision impairment.
• Starting January 1, 2026, California’s Medi-Cal program will stop covering GLP-1 drugs when used only for weight-loss or weight-related indications. Coverage remains if the drug is used for diabetes or other approved non-weight-loss indications.
• This policy change primarily affects low-income Californians who rely on Medi-Cal for access to expensive GLP-1 medications. It means many will have to pay out of pocket, likely $500-$1,200/month (or more) if they continue treatment.
• GLP-1 medications (like semaglutide, tirzepatide) were originally for diabetes but doctors saw significant weight-loss results and now they’re used for that purpose. They work by suppressing appetite, increasing fullness, slowing gastric emptying, improving metabolism, and reducing cravings.
• My own experience: tough on the front end (nausea, stomach issues, headaches, zero appetite) but now stabilized. I’ve lost 40 lbs but could have done more if I exercised more. My unique circumstance (vision impairment, inability to drive) makes exercise harder.
• Alternative route: using an online service like Weightcare to get prescribed GLP-1s regardless of Medi-Cal coverage changes. They offer virtual doctor visits, drug prescriptions, support (dietician, nutritionist), supplements, and crucially — a discount code for savings.
• Drugs available through Weightcare: semaglutide (GLP-1 only) and tirzepatide (dual GIP+GLP-1), each with pros/cons (mechanism, weight-loss potential, cost, side-effects).
• We walked through how to get set up: visit website, consult doctor, get prescription, enroll in program, use discount code — preferably before Jan 1 2026 to avoid disruption.
• The message is: you’re not alone. If you’re on Medi-Cal using weight-loss GLP-1s, or plan to be, this affects you. It affects me. We all share this concern.
Conclusion & Call to Action.
Here’s where I wrap it up — but also where I ask you to act. If you’re reading this and you’re in California, on Medi-Cal or relying on it, and you’re either using or considering using a GLP-1 drug for weight loss — you need to pay attention. January 1, 2026 is the date. After that, you may lose coverage for that drug unless your doctor prescribes it for diabetes or an approved non-weight-loss condition, and your Medi-Cal plan codes it correctly. That means the medication may go from (effectively) free at point-of-care to hundreds or thousands of dollars per month out-of-pocket.
For me, I feel the urgency. It’s not fair that something I fought to start — a shot that’s finally working — might be taken away because of budget decisions. I’m asking you: take control now. Set up your backup plan. If you can, go through Weightcare (my favorite) and get everything lined up in case the coverage change hits you. Use my discount code at checkout — yes, I’ll share it — because every dollar you save counts. Don’t wait till the last minute and risk missing doses or losing momentum.
We’re in this together. Me. You. Dozens, hundreds, thousands of Californians on Medi-Cal using GLP-1s for weight loss or thinking about it. Let’s move proactively. Use my discount code with Weightcare, enroll, get your virtual doctor appointment, get your prescription and support lined up before January 1, 2026. That way you’re not scrambling; you’re ready.
This isn’t just about weight. It’s about health, dignity, progress, and continuity. If you’ve invested in your health, worked up the courage to start a GLP-1 journey, don’t let a policy change pull the rug out from under you. Use the tools available. Use the options. Use the discount. And keep going. Let’s do this.
~ Written by Rachael Tam.
~ Photos by Weightcare.
~ Brand - Weightcare.
~ For PR Offers, email me at - bfh.artistry@gmail.com.
~ My Linktree link - https://linktr.ee/rachaeltam.
~ Shop my Amazon Storefront.
~ Check out my ShopMy Store.
~ Shop my Walmart Storefront.
~ Check out my Ulta Beauty Storefront.
~ Shop my Kitsch Store.
~ Check out my Target Storefront.
Comments
Post a Comment